Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

BJU International

Volumn 114, Issue 3, 2014, Pages 334-339

  Dalpiaz, Orietta ^a   Ehrlich, Georg C ^a   Mannweiler, Sebastian ^a   Hernández, Jessica M Martín ^a   Gerger, Armin ^a   Stojakovic, Tatjana ^a   Pummer, Karl ^a   Zigeuner, Richard ^a   Pichler, Martin ^a   Hutterer, Georg C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

neutrophil lymphocyte ratio; prognosis; upper tract urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SEGMENTAL URETERECTOMY; TERTIARY HEALTH CARE; TRANSITIONAL CELL CARCINOMA; URETER SURGERY; VERY ELDERLY;

NEUTROPHIL-LYMPHOCYTE RATIO; PROGNOSIS; UPPER TRACT UROTHELIAL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTES; MALE; NEUTROPHILS; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; UROTHELIUM;

EID: 84906672209     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12441     Document Type: Article

References (24)

1. Rouprêt M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
3. Fajkovic H, Cha EK, Xylinas E, et al. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol 2013; 31: 5-11
4. Drouin SJ, Yates DR, Hupertan V, Cussenot O, Rouprêt M,. A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting. World J Urol 2013; 31: 109-116
5. Rouprêt M, Hupertan V, Seisen T, et al.; French National Database on Upper Tract Tumors; Upper Tract Urothelial Carcinoma Collaboration. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 2013; 189: 1662-1669
6. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-581
7. Margulis V, Youssef RF, Karakiewicz PI, et al.; Upper Tract Urothelial Carcinoma Collaborative Group. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010; 184: 453-458
8. Roxburgh CS, Crozier JE, Maxwell F, et al. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer 2009; 100: 701-706
9. Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013; 108: 901-907
10. Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009; 58: 15-23
11. Perez DR, Baser RE, Cavnar MJ, et al. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol 2013; 20: 593-599
12. Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 2012; 79: 1085-1091
13. Hashimoto T, Ohno Y, Nakashima J, Gondo T, Ohori M, Tachibana M,. Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World J Urol 2013; 31: 953-958
14. Sobin L, Gospodarowicz M, Wittekind C,. TNM Classification of Malignant Tumours. Urological Tumours. Renal Pelvis and Ureter, 7th revised edn. Chichester: Wiley-Blackwell, UICC, 2009: 258-261. Available at: http://www.uicc.org/tnm/. Accessed 2010
15. Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R,. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 2004; 45: 257-266 (Pubitemid 38221396)
16. Mayr R, May M, Martini T, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomyfor urothelial carcinoma of the bladder. Eur Urol 2012; 62: 662-670
17. Atzpodien J, Royston P, Wandert T, Reitz M Br J,; DGCIN-German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 2003; 88: 348-353 (Pubitemid 36308143)
18. Shariat SF, Godoy G, Lotan Y, et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 2010; 105: 1672-1677
19. Rouprêt M, Wallerand H, Traxer O, et al. Checkup and management of upper urinary tract tumours in 2010: an update from the committee of cancer from the French National Association of Urology. Prog Urol 2010; 20: 260-271
20. Jeldres C, Sun M, Lughezzani G, et al. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 2010; 116: 3774-3784
21. Novara G, De Marco V, Gottardo F, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007; 110: 1715-1722 (Pubitemid 47557295)
22. Tanaka N, Kikuchi E, Shirotake S, et al. The predictive value of c-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Eur Urol 2012 doi: 10.1016/j.eururo.2012.11.050. [Epub ahead of print]
23. Obata J, Kikuchi E, Tanaka N, et al. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy. Urol Oncol 2012 doi: 10.1016/j.urolonc.2012.05. 008. [Epub ahead of print]
24. Tanaka N, Kikuchi E, Matsumoto K, et al. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma. BJU Int 2013; 111: 857-864